Publisher: Karger
E-ISSN: 1421-9670|19|3|411-415
ISSN: 0250-8095
Source: American Journal of Nephrology, Vol.19, Iss.3, 1999-06, pp. : 411-415
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Thirty-one renal transplant recipients, submitted to treatment with cyclosporin in association with other immunosuppressive agents, were also treated for 9 months with two hydroxymethylglutaryl coenzyme A reductase inhibitors, simvastatin (10 mg/day) or pravastatin (20 mg/day), for concomitant hypercholesterolemia and hypertriglyceridemia. Both drugs significantly decreased total cholesterol and triglyceride serum levels, but they did not modify whole-blood trough concentrations of polyclonal and monoclonal cyclosporin or polyclonal/monoclonal cyclosporin ratio. No alterations of the clinical and laboratory parameters investigated were found. The results of this study show the efficacy and safety of hydroxymethylglutaryl coenzyme A reductase inhibitors in the treatment of hyperlipidemia in kidney transplant patients.
Related content
Effects of Mediterranean Diet on Lipid Levels and Cardiovascular Risk in Renal Transplant Recipients
Nephron, Vol. 82, Iss. 3, 1999-06 ,pp. :
Nephron, Vol. 81, Iss. 3, 1999-02 ,pp. :
Endogenous Erythropoietin Levels and Anemia in Long-Term Renal Transplant Recipients
Kidney and Blood Pressure Research, Vol. 30, Iss. 2, 2007-03 ,pp. :
QT Dispersion in Renal Transplant Recipients
Nephron, Vol. 91, Iss. 2, 2002-06 ,pp. :